The plant cell growth company
Our patented biofarming technology enables us to produce specific types of plant cells without having to grow the plant. This means low cost and high-quality core ingredients for pharmaceutical, nutraceutical and supplement producers
BioHarvest Sciences has a clear Path to Commercialization:
- Manufacturing agreement with Sugart to provide 20 Ton capacity facility for 2021
- September 2020 – signed US Distribution agreement with Batory Foods for up to $18 Million of Vinia over 7 years
- Vinia product is currently available to consumers in Israel, with US B2C introduction expected in early 2021
- Over $30 Million CAD spent on Research and Development
- Patented technology
- Proven Management team on both Product Development and Commercialization
- Low Cap Ex alternative to traditional agricuture that will allow scaleable production of ingredients such as hemp based CBD, grape, olive, and pomegranate products
Recent News Releases
Investor Inquiries
-
Ilan Sobel
CEO-
E-MAIL
Ilan@bioharvest.com
-
-
David Ryan
VP IR-
E-MAIL
dave@bioharvest.com -
PHONE
CA - 1-604-622-1186
-
-
Justin Meiklem
IR Consultant-
E-MAIL
justin@bioharvest.com -
PHONE
CA - 778-686-3855
-
